A double blind, randomised placebo controlled study of the safety, reactogenicity and immunogenicity of two doses of orally administered human rotavirus vaccine (RIX4414) in healthy infants in South A...

Mise à jour : Il y a 4 ans
Référence : ISRCTN37373664

A double blind, randomised placebo controlled study of the safety, reactogenicity and immunogenicity of two doses of orally administered human rotavirus vaccine (RIX4414) in healthy infants in South Africa

Femme et Homme

Extrait

Not provided at time of registration


Critère d'inclusion

  • Vaccine/immunization

Liens